Biological Barriers in the Treatment of Alcoholism

Author(s):  
David M. Lawson ◽  
Michelle Craske
Keyword(s):  
1991 ◽  
Vol 36 (7) ◽  
pp. 641-641
Author(s):  
No authorship indicated

2016 ◽  
Vol 22 (9) ◽  
pp. 1259-1273 ◽  
Author(s):  
Carolyn Jordan ◽  
Vladimir V. Shuvaev ◽  
Mark Bailey ◽  
Vladimir R. Muzykantov ◽  
Thomas D. Dziubla

2013 ◽  
Vol 19 (37) ◽  
pp. 6691-6697 ◽  
Author(s):  
Zhe Wang ◽  
Guangbo Qu ◽  
Lina Su ◽  
Lei Wang ◽  
Zuozhi Yang ◽  
...  

Author(s):  
Miguel Gisbert-Garzarán ◽  
Daniel Lozano ◽  
Kotaro Matsumoto ◽  
Aoi Komatsu ◽  
Miguel Manzano ◽  
...  

Pharmaceutics ◽  
2021 ◽  
Vol 13 (1) ◽  
pp. 122 ◽  
Author(s):  
Rebekah Omarkhail Elliott ◽  
Mei He

Since the 2013 Nobel Prize was awarded for the discovery of vesicle trafficking, a subgroup of nanovesicles called exosomes has been driving the research field to a new regime for understanding cellular communication. This exosome-dominated traffic control system has increased understanding of many diseases, including cancer metastasis, diabetes, and HIV. In addition to the important diagnostic role, exosomes are particularly attractive for drug delivery, due to their distinctive properties in cellular information transfer and uptake. Compared to viral and non-viral synthetic systems, the natural, cell-derived exosomes exhibit intrinsic payload and bioavailability. Most importantly, exosomes easily cross biological barriers, obstacles that continue to challenge other drug delivery nanoparticle systems. Recent emerging studies have shown numerous critical roles of exosomes in many biological barriers, including the blood–brain barrier (BBB), blood–cerebrospinal fluid barrier (BCSFB), blood–lymph barrier (BlyB), blood–air barrier (BAB), stromal barrier (SB), blood–labyrinth barrier (BLaB), blood–retinal barrier (BRB), and placental barrier (PB), which opens exciting new possibilities for using exosomes as the delivery platform. However, the systematic reviews summarizing such discoveries are still limited. This review covers state-of-the-art exosome research on crossing several important biological barriers with a focus on the current, accepted models used to explain the mechanisms of barrier crossing, including tight junctions. The potential to design and engineer exosomes to enhance delivery efficacy, leading to future applications in precision medicine and immunotherapy, is discussed.


Nanoscale ◽  
2021 ◽  
Vol 13 (12) ◽  
pp. 5954-5964
Author(s):  
Jinyu Rong ◽  
Yuan He ◽  
Juanjuan Tang ◽  
Ruxia Qiao ◽  
Sijie Lin

Understanding nano–bio interactions is pivotal to the safe implementation of nanotechnology for both biological and environmental applications.


Author(s):  
Yumei Wang ◽  
Kaijun Gou ◽  
Xianmou Guo ◽  
Jia Ke ◽  
Sanming Li ◽  
...  

2018 ◽  
Vol 9 ◽  
Author(s):  
Sangram Raut ◽  
Linda Mooberry ◽  
Nirupama Sabnis ◽  
Ashwini Garud ◽  
Akpedje Serena Dossou ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document